Annandale Capital’s Oscar Health OSCR Stock Holding History

Annandale Capital’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-45,000	Closed	-$852K	–	138
2025 Q3	$852K	Hold	45,000	–	–	0.14%	75
2025 Q2	$965K	Buy	+45,000	New	+$669K	0.07%	75

Other funds holding OSCR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TCMNY

Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

BIT Capital Berlin, Germany $3.38B AUM 214.12% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Annandale Capital's OSCR Position: Q4 2025 in Review

Annandale Capital sold out of Oscar Health (OSCR) in Q4 2025, closing a stake of 45,000 shares — an estimated $852K sold.

Annandale Capital first reported a position in OSCR in Q2 2025 and held it in 2 quarters. The position peaked at $965K in Q2 2025. 343 funds tracked by Wall St. Rank hold OSCR as of Q4 2025.

Annandale Capital reported no remaining Oscar Health position as of Q4 2025 after selling out during the quarter.
Annandale Capital sold 45,000 Oscar Health shares in Q4 2025, an estimated $852K.
Annandale Capital first reported a position in Oscar Health in Q2 2025 and held it in 2 quarters.
Annandale Capital's Oscar Health position peaked at $965K in Q2 2025.
343 funds tracked by Wall St. Rank held Oscar Health as of Q4 2025.

Based on Annandale Capital's 13F filing for Q4 2025, filed 12 Feb 2026.